Literature DB >> 14578210

A golden hamster model for human acute Nipah virus infection.

K Thong Wong1, Isabelle Grosjean, Christine Brisson, Barissa Blanquier, Michelle Fevre-Montange, Arlette Bernard, Philippe Loth, Marie-Claude Georges-Courbot, Michelle Chevallier, Hideo Akaoka, Philippe Marianneau, Sai Kit Lam, T Fabian Wild, Vincent Deubel.   

Abstract

A predominantly pig-to-human zoonotic infection caused by the novel Nipah virus emerged recently to cause severe morbidity and mortality in both animals and man. Human autopsy studies showed the pathogenesis to be related to systemic vasculitis that led to widespread thrombotic occlusion and microinfarction in most major organs especially in the central nervous system. There was also evidence of extravascular parenchymal infection, particularly near damaged vessels (Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith CS, Chua KB, Lam SK, Tan CT, Goh KJ, Chong HT, Jusoh R, Rollin PE, Ksiazek TG, Zaki SR, Nipah Virus Pathology Working Group: Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 2002, 161:2153-2167). We describe here a golden hamster (Mesocricetus auratus) model that appears to reproduce the pathology and pathogenesis of acute human Nipah infection. Hamsters infected by intranasal or intraperitoneal routes died within 9 to 29 days or 5 to 9 days, respectively. Pathological lesions were most severe and extensive in the hamster brain. Vasculitis, thrombosis, and more rarely, multinucleated endothelial syncytia, were found in blood vessels of multiple organs. Viral antigen and RNA were localized in both vascular and extravascular tissues including neurons, lung, kidney, and spleen, as demonstrated by immunohistochemistry and in situ hybridization, respectively. Paramyxoviral-type nucleocapsids were identified in neurons and in vessel walls. At the terminal stage of infection, virus and/or viral RNA could be recovered from most solid organs and urine, but not from serum. The golden hamster is proposed as a suitable model for further studies including pathogenesis studies, anti-viral drug testing, and vaccine development against acute Nipah infection.

Entities:  

Mesh:

Year:  2003        PMID: 14578210      PMCID: PMC1892425          DOI: 10.1016/S0002-9440(10)63569-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Treatment of acute Nipah encephalitis with ribavirin.

Authors:  H T Chong; A Kamarulzaman; C T Tan; K J Goh; T Thayaparan; S R Kunjapan; N K Chew; K B Chua; S K Lam
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

Review 2.  Comparative pathology of the diseases caused by Hendra and Nipah viruses.

Authors:  P Hooper; S Zaki; P Daniels; D Middleton
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

3.  Introduction to Current focus on Hendra and Nipah viruses.

Authors:  B T Eaton
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

4.  A guinea-pig model of Hendra virus encephalitis.

Authors:  M M Williamson; P T Hooper; P W Selleck; H A Westbury; R F Slocombe
Journal:  J Comp Pathol       Date:  2001-05       Impact factor: 1.311

5.  Risk factors for Nipah virus infection among abattoir workers in Singapore.

Authors:  M H Chew; P M Arguin; D K Shay; K T Goh; P E Rollin; W J Shieh; S R Zaki; P A Rota; A E Ling; T G Ksiazek; S K Chew; L J Anderson
Journal:  J Infect Dis       Date:  2000-05-03       Impact factor: 5.226

6.  Nipah virus: a recently emergent deadly paramyxovirus.

Authors:  K B Chua; W J Bellini; P A Rota; B H Harcourt; A Tamin; S K Lam; T G Ksiazek; P E Rollin; S R Zaki; W Shieh; C S Goldsmith; D J Gubler; J T Roehrig; B Eaton; A R Gould; J Olson; H Field; P Daniels; A E Ling; C J Peters; L J Anderson; B W Mahy
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

7.  The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia.

Authors:  K B Chua; S K Lam; K J Goh; P S Hooi; T G Ksiazek; A Kamarulzaman; J Olson; C T Tan
Journal:  J Infect       Date:  2001-01       Impact factor: 6.072

8.  Clinical features of Nipah virus encephalitis among pig farmers in Malaysia.

Authors:  K J Goh; C T Tan; N K Chew; P S Tan; A Kamarulzaman; S A Sarji; K T Wong; B J Abdullah; K B Chua; S K Lam
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

9.  Risk factors for Nipah virus transmission, Port Dickson, Negeri Sembilan, Malaysia: results from a hospital-based case-control study.

Authors:  N M Amal; M S Lye; T G Ksiazek; P D Kitsutani; K S Hanjeet; M A Kamaluddin; F Ong; S Devi; P C Stockton; O Ghazali; R Zainab; M A Taha
Journal:  Southeast Asian J Trop Med Public Health       Date:  2000-06       Impact factor: 0.267

10.  Relapsed and late-onset Nipah encephalitis.

Authors:  Chong Tin Tan; Khean Jin Goh; Kum Thong Wong; Sazilah Ahmad Sarji; Kaw Bing Chua; Nee Kong Chew; Paramsothy Murugasu; Yet Lin Loh; Heng Thay Chong; Kay Sin Tan; Tarmizi Thayaparan; Shalini Kumar; Mohd Rani Jusoh
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

View more
  103 in total

Review 1.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

2.  Nipah virus: vaccination and passive protection studies in a hamster model.

Authors:  V Guillaume; H Contamin; P Loth; M-C Georges-Courbot; A Lefeuvre; P Marianneau; K B Chua; S K Lam; R Buckland; V Deubel; T F Wild
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Recombinant nipah virus vaccines protect pigs against challenge.

Authors:  Hana M Weingartl; Yohannes Berhane; Jeff L Caswell; Sheena Loosmore; Jean-Christophe Audonnet; James A Roth; Markus Czub
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

5.  A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species.

Authors:  Kathrin Hagmaier; Nicola Stock; Steve Goodbourn; Lin-Fa Wang; Richard Randall
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

6.  Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.

Authors:  Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Andrew C Hickey; Mark A Smith; Yee-Peng Chan; Lin-Fa Wang; Joseph J Mattapallil; Joan B Geisbert; Katharine N Bossart; Christopher C Broder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

7.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

8.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

9.  Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail.

Authors:  Lena Thiel; Sandra Diederich; Stephanie Erbar; Dennis Pfaff; Hellmut G Augustin; Andrea Maisner
Journal:  Virol J       Date:  2008-12-24       Impact factor: 4.099

10.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.